subscribeSubscribe
FDA revises guidance on predicting Alzheimer`s drug benefits

FDA revises guidance on predicting Alzheimer`s drug benefits
Gabrielle Masson FIERCE BIOTECH
12 Mar 2024
Share Share
Biogen drops Alzheimer`s drug Aduhelm, ending a 17-year chapter

Biogen drops Alzheimer`s drug Aduhelm, ending a 17-year chapter
REUTERS
01 Feb 2024
Share Share
Biogen comes out ahead in Aduhelm-related investor lawsuit

Biogen comes out ahead in Aduhelm-related investor lawsuit
Zoey Becker FIERCE PHARMA
31 Mar 2023
Share Share
VA to cover Eisai`s new Alzheimer`s drug after declining to cover Aduhelm

VA to cover Eisai`s new Alzheimer`s drug after declining to cover Aduhelm
Zachary Brennan ENDPTS
14 Mar 2023
Share Share
Dunn with the FDA: head of agency`s neuroscience unit to depart

Dunn with the FDA: head of agency`s neuroscience unit to depart
Max Bayer FIERCE BIOTECH
27 Feb 2023
Share Share
FDA adds warning of `larger areas of bleeding` in brain to Aduhelm label

FDA adds warning of `larger areas of bleeding` in brain to Aduhelm label
ENDPTS
15 Feb 2023
Share Share
Biogen`s Biologic ADUHELM (Aducanumab) Receives Approval in the U.S.

Biogen`s Biologic ADUHELM (Aducanumab) Receives Approval in the U.S.
FDA
08 Feb 2023
Share Share
Eisai files for approval of Alzheimer`s drug in Europe

Eisai files for approval of Alzheimer`s drug in Europe
REUTERS
11 Jan 2023
Share Share
Eisai taps its native tongue for new Alzheimer`s drug Leqembi

Eisai taps its native tongue for new Alzheimer`s drug Leqembi
Ben Adams FIERCE PHARMA
09 Jan 2023
Share Share
Congressional inquiry into `highly atypical` FDA-Biogen ties ends damning report

Congressional inquiry into `highly atypical` FDA-Biogen ties ends damning report
Zachary Brennan ENDPTS
03 Jan 2023
Share Share